Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry
Table 1
Inclusion and exclusion criteria
Inclusion criteria
Exclusion criteria
Age 18–85 years
Contraindications to use of tirofiban
STEMI within 12 hours from symptoms onset with high thrombus burden
Patients with left bundle branch block
ST-segment elevation >1 mm in 2 adjacent ECG leads
Therapy resistant cardiogenic shock
Patients eligible for primary PCI within 120 minutes after first medical contact
Persistent severe hypertension (systolic BP >180 mmHg or diastolic BP >110 mmHg)